Mercaptopurine (Quinn Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Mercaptopurine drug offered from Quinn Pharmaceuticals, LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Quinn Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | Mercaptopurine |
SUBSTANCE NAME: | MERCAPTOPURINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2016-10-05 |
END MARKETING DATE: | 0000-00-00 |
Mercaptopurine HUMAN PRESCRIPTION DRUG Details:
Item Description | Mercaptopurine from Quinn Pharmaceuticals, LLC |
LABELER NAME: | Quinn Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2016-10-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69076-913_752460b7-86dc-42dc-85fe-3aae07788f51 |
PRODUCT NDC: | 69076-913 |
APPLICATION NUMBER: | NDA009053 |
Other MERCAPTOPURINE Pharmaceutical Manufacturers / Labelers: